Orasure Technologies Inc.

NASDAQ:OSUR  
9.36
-0.12 (-1.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)664.99M
Current PEN/A
Forward PE 16.71
2yr Forward PE 17.02
See more stats
Estimates Current Quarter
Revenue$59.42 Million
Adjusted EPS$0.09
See more estimates
10-Day MA$9.50
50-Day MA$9.60
200-Day MA$11.74
See more pivots

Orasure Technologies Inc. Stock, NASDAQ:OSUR

220 East 1st Street, Bethlehem, Pennsylvania 18015
United States of America
Phone: +1.610.882.1820
Number of Employees: 570

Description

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.